Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
NCT ID:
NCT03077451
Group ID:
EG001
Title:
Standard Dose Treatment (Nelfinavir Mesylate)
Description:
This study is not parallel arm study. Nelfinavir dose will be administrated in the sequential manner according to the response.
AE summary is based on participants who received standard dose. There were totally 36 participants received standard dose initally.
All patients will received standard dose of nelfinavir (1250 mg BID) for at least 4 weeks. If there is complete response (CR) at any time at the standard dose, nelfinavir will be discontinued 4 weeks after documentation of CR.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
36
Other Number Affected:
5
Other Number At Risk:
36
Study:
NCT03077451
Results Section:
NCT03077451
Adverse Events Module:
NCT03077451